An investigation into transmission and total cases of Crimean-Congo haemorrhagic fever (CCHF) in Uganda

Grant number: 227120

Grant search

Key facts

  • Disease

    Crimean-Congo haemorrhagic fever
  • Start & end year

    2022
    2025
  • Funder

    Wellcome Trust
  • Principal Investigator

    Ms. Marina Kugler
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Glasgow
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Crimean-Congo haemorrhagic fever virus (CCHFV) is endemic in Uganda, shown by high seroprevalence in humans and animals. Sporadic outbreaks are regularly reported in humans in areas considered to be at highest risk within the Ugandan cattle corridor. However, recently we have detected cases of undiagnosed CCHF in patients presenting with acute febrile illness in other parts of the country. The incidence and prevalence of CCHF across Uganda and the extent of the health burden is not known. In this study, we will carry out a country-wide, longitudinal seroprevalence study to assess parts of the country most at risk. We will investigate risk factors using quantitative and qualitative approaches. With a mechanistic mathematical model, I aim to investigate the burden of CCHFV infection in Uganda. This will help to inform policy makers about the burden of CCHF on the health care system and will inform about the need to improve diagnostics for viral infections, thereby reducing misdiagnosis. Additionally, the model can later be used to show the effectiveness of interventions against infection with CCHFV.